50 results found in news
news
CareAcross content
CareAcross
Posted about 5 years ago
Two-drug combination, nab-paclitaxel and gemcitabine, improves survival in pancreatic cancer
A multicentre phase III study, with centers participating from 11 countries in North America, Europe and Australia, shows that the drug combination nab-paclitaxel and gemcitabine is more effective in the treatment of patients with advanced pancreatic cancer than gemcitabine alone, which has been the standard treatment for these patients up until now.
Read full article